|

The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders

RECRUITINGN/ASponsored by Peking University
Actively Recruiting
PhaseN/A
SponsorPeking University
Started2026-03
Est. completion2028-05
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted

Summary

The goal of this clinical trial is to evaluate the effectiveness and cost-effectiveness of a digital mindfulness-based intervention in adults (aged 18-65) diagnosed with emotional disorders like depression or anxiety. The main questions it aims to answer are: * Does adding a digital mindfulness intervention to usual care help people recover from emotional disorders faster and more sustainably over two years? * Is this combined approach more cost-effective than usual care alone? Researchers will compare the group receiving the digital mindfulness intervention plus their usual treatment to the group receiving only their usual treatment to see if the intervention leads to better long-term recovery and represents good value for money. Participants in the intervention group will: * Attend eight weekly 2-hour online group mindfulness sessions. * Use a WeChat mini-program for 49 days of guided mindfulness exercises and daily tasks. * Patients who have not achieved reliable recovery after group retraining voluntarily participate in individual UP\&MIED counseling. * Complete regular questionnaires and interviews over two years to track their progress. All participants will continue to receive their usual medical care from their doctors throughout the study.

Eligibility

Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Age: 18-65 years.
2. Diagnosed with an emotional disorder by a psychiatrist (distinguishing primary and comorbid diagnoses during assessment) and meeting criteria on the Mini-International Neuropsychiatric Interview (MINI), including depressive disorders, anxiety disorders (e.g., generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder), obsessive-compulsive disorder, post-traumatic stress disorder, and eating disorders (e.g., anorexia nervosa, bulimia nervosa).
3. Symptom severity meeting the threshold: PHQ-9 score ≥10 or GAD-7 score ≥8.

Exclusion Criteria:

1. Current diagnosis of psychotic disorders or bipolar disorder.
2. Current organic mental disorders, pervasive developmental disorders, severe cognitive impairment, or substance use disorders.
3. Current suicide risk (moderate or higher suicide risk on the MINI suicide module).
4. Antisocial personality disorder.
5. Severe medical illnesses that may affect intervention participation or require recent hospitalization.
6. Previous participation in a systematic 8-week mindfulness course.
7. Inability to access the internet.

Conditions8

AnxietyAnxiety DisordersDepressionDepressive DisorderEating DisordersEmotional DisordersObsessive-compulsive DisorderPost Traumatic Stress Disorder (PTSD)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.